Al-Horani R (2014) Serpin regulation of fibrinolytic system: implications for therapeutic applications in cardiovascular diseases. Cardiovasc Hematol Agents Med Chem 12:91–125. https://doi.org/10.2174/1871525712666141106095927

Article  CAS  PubMed  Google Scholar 

Amara U, Flierl M, Rittirsch D, Klos A, Chen H, Acker B et al (2010) Molecular intercommunication between the complement and coagulation systems. J Immunol 185:5628–5636. https://doi.org/10.4049/Jimmunol.0903678

Article  CAS  PubMed  Google Scholar 

Antalis T, La Linn M, Donnan K, Mateo L, Gardner J, Dickinson J et al (1998) The serine proteinase inhibitor (serpin) plasminogen activation inhibitor type 2 protects against viral cytopathic effects by constitutive interferon alpha/beta priming. J Exp Med 187:1799–1811. https://doi.org/10.1084/Jem.187.11.1799

Article  CAS  PubMed  PubMed Central  Google Scholar 

Berk R, Katar M, Dong Z, Day D (2001) Plasminogen activators and inhibitors in the corneas of mice infected with pseudomonas aeruginosa. Invest Ophthalmol Vis Sci 42:1561–1567

CAS  PubMed  Google Scholar 

Bijlsma M, Brouwer M, Kasanmoentalib E, Kloek A, Lucas M, Tanck M et al (2016) Community-acquired bacterial meningitis in adults in the Netherlands, 2006–14: a prospective cohort study. Lancet Infect Diseas 16:339–347. https://doi.org/10.1016/S1473-3099(15)00430-2

Article  Google Scholar 

Brouwer M, Heckenberg S, De Gans J, Spanjaard L, Reitsma J, Van De Beek D (2010) Nationwide implementation of adjunctive dexamethasone therapy for pneumococcal meningitis. Neurology 75:1533–1539. https://doi.org/10.1212/Wnl.0b013e3181f96297

Article  CAS  PubMed  Google Scholar 

Brouwer M, Meijers J, Baas F, Van Der Ende A, Pfister H, Giese A et al (2014) Plasminogen activator inhibitor-1 influences cerebrovascular complications and death in pneumococcal meningitis. Acta Neuropathol 127:553–564. https://doi.org/10.1007/S00401-013-1216-4

Article  CAS  PubMed  Google Scholar 

Buchthal B, Weiss U, Bading H (2018) Post-injury nose-to-brain delivery of activin a and serpinb2 reduces brain damage in a mouse stroke model. Mol Ther 26:2357–2365. https://doi.org/10.1016/J.Ymthe.2018.07.018

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chuang S, Yang C, Chou C, Chiang Y, Chuang T, Hsu L (2013) Tlr-Induced pai-2 expression suppresses Il-1beta processing via increasing autophagy and Nlrp3 degradation. Proc Natl Acad Sci U S A 110:16079–16084. https://doi.org/10.1073/Pnas.1306556110

Article  CAS  PubMed  PubMed Central  Google Scholar 

Croucher D, Saunders D, Lobov S, Ranson M (2008) Revisiting the biological roles of pai2 (serpinb2) in cancer. Nat Rev Cancer 8:535–545. https://doi.org/10.1038/Nrc2400

Article  CAS  PubMed  Google Scholar 

Dougherty K, Pearson J, Yang A, Westrick R, Baker M, Ginsburg D (1999) The plasminogen activator inhibitor-2 gene is not required for normal murine development or survival. Proc Natl Acad Sci U S A 96:686–691. https://doi.org/10.1073/Pnas.96.2.686

Article  CAS  PubMed  PubMed Central  Google Scholar 

Foley J, Walton B, Aleman M, Obyrne A, Lei V, Harrasser M et al (2016) Complement activation in arterial and venous thrombosis is mediated by plasmin. EBioMedicine 5:175–182. https://doi.org/10.1016/J.Ebiom.2016.02.011

Article  PubMed  PubMed Central  Google Scholar 

Gan H, Lee J, Ren F, Chen M, Kornfeld H, Remold H (2008) Mycobacterium tuberculosis blocks crosslinking of annexin-1 and apoptotic envelope formation on infected macrophages to maintain virulence. Nat Immunol 9:1189–1197. https://doi.org/10.1038/Ni.1654

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gan H, Newman G, Remold H (1995) Plasminogen activator inhibitor type 2 prevents programmed cell death of human macrophages infected with mycobacterium avium, serovar 4. J Immunol 155:1304–1315

CAS  PubMed  Google Scholar 

Gardiner E, Medcalf R (2014) Is plasminogen activator inhibitor type 2 really a plasminogen activator inhibitor after all? J Thromb Haemost 12:1703–1705. https://doi.org/10.1111/Jth.12704

Article  CAS  PubMed  Google Scholar 

Grandgirard D, Gaumann R, Coulibaly B, Dangy J, Sie A, Junghanss T et al (2013) The causative pathogen determines the inflammatory profile in cerebrospinal fluid and outcome in patients with bacterial meningitis. Mediators Inflamm. https://doi.org/10.1155/2013/312476

Article  PubMed  PubMed Central  Google Scholar 

Greten F, Arkan M, Bollrath J, Hsu L, Goode J, Miething C et al (2007) Nf-kappab is a negative regulator of Il-1beta secretion as revealed by genetic and pharmacological inhibition of ikkbeta. Cell 130:918–931. https://doi.org/10.1016/J.Cell.2007.07.009

Article  CAS  PubMed  PubMed Central  Google Scholar 

Griemert E, Hedrich J, Hirnet T, Thal S (2019) Deficiency of plasminogen activator inhibitor type 2 limits brain edema formation after traumatic brain injury. J Neurotrauma 36:2272–2278. https://doi.org/10.1089/Neu.2018.6126

Article  PubMed  Google Scholar 

Griemert E, Recarte-Pelz K, Engelhard K, Schafer M, Thal S (2019) Pai-1 but not pai-2 gene deficiency attenuates ischemic brain injury after experimental stroke. Transl Stroke Res 10:372–380. https://doi.org/10.1007/S12975-018-0644-9

Article  PubMed  Google Scholar 

Haile W, Coleman J, Benach J (2006) Reciprocal upregulation of urokinase plasminogen activator and its inhibitor, pai-2, by borrelia burgdorferi affects bacterial penetration and host-inflammatory response. Cell Microbiol 8:1349–1360. https://doi.org/10.1111/J.1462-5822.2006.00717.X

Article  PubMed  Google Scholar 

Haj M, Robbie L, Adey G, Bennett B (1995) Inhibitors of plasminogen activator in neutrophils and mononuclear cells from septic patients. Thromb Haemost 74:1528–1532

Article  CAS  PubMed  Google Scholar 

Hoegen T, Tremel N, Klein M, Angele B, Wagner H, Kirschning C et al (2011) The Nlrp3 inflammasome contributes to brain injury in pneumococcal meningitis and is activated through atp-dependent lysosomal cathepsin B release. J Immunol 187:5440–5451. https://doi.org/10.4049/Jimmunol.1100790

Article  CAS  PubMed  Google Scholar 

Iwaki T, Urano T, Umemura K (2012) Pai-1, progress in understanding the clinical problem and its aetiology. Br J Haematol 157:291–298. https://doi.org/10.1111/J.1365-2141.2012.09074.X

Article  CAS  PubMed  Google Scholar 

Koedel U, Bernatowicz A, Frei K, Fontana A, Pfister H (1996) Systemically (but not intrathecally) administered il-10 attenuates pathophysiologic alterations in experimental pneumococcal meningitis. J Immunol 157:5185–5191

CAS  PubMed  Google Scholar 

Lees J, Ferwerda B, Kremer P, Wheeler N, Seron M, Croucher N et al (2019) Joint sequencing of human and pathogen genomes reveals the genetics of pneumococcal meningitis. Nat Commun 10:2176. https://doi.org/10.1038/S41467-019-09976-3

Article  PubMed  PubMed Central  Google Scholar 

Leung L, Morser J (2016) Plasmin as a complement C5 convertase. EBioMedicine 5:20–21. https://doi.org/10.1016/J.Ebiom.2016.03.015

Article  PubMed  PubMed Central  Google Scholar 

Major L, Partridge T, Gardner J, Kent S, De Rose R, Suhrbier A et al (2013) Induction of serpinb2 and Th1/Th2 modulation by serpinb2 during lentiviral infections in vivo. PLoS ONE 8:E57343. https://doi.org/10.1371/Journal.Pone.0057343

Article  CAS  PubMed  PubMed Central  Google Scholar 

Manzanillo P, Eidenschenk C, Ouyang W (2015) Deciphering the crosstalk among Il-1 and Il-10 family cytokines in intestinal immunity. Trends Immunol 36:471–478. https://doi.org/10.1016/J.It.2015.06.003

Article  CAS  PubMed  Google Scholar 

Medcalf R, Stasinopoulos S (2005) The undecided serpin. The ins and outs of plasminogen activator inhibitor type 2. Febs J 272:4858–4867. https://doi.org/10.1111/J.1742-4658.2005.04879.X

Article  CAS  PubMed  Google Scholar 

Mukhopadhyay S, Ta J, Sarkar R, Tm A (2018) Serpins in venous thrombosis and venous thrombus resolution. Methods Mol Biol 1826:197–211. https://doi.org/10.1007/978-1-4939-8645-3_13

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ouyang W, Ogarra A (2019) Il-10 family cytokines Il-10 and Il-22: from basic science to clinical translation. Immunity 50:871–891. https://doi.org/10.1016/J.Immuni.2019.03.020

Article  CAS  PubMed  Google Scholar 

Paramo J, Perez J, Serrano M, Rocha E (1990) Types 1 and 2 plasminogen activator inhibitor and tumor necrosis factor alpha in patients with sepsis. Thromb Haemost 64:3–6

Article  CAS  PubMed  Google Scholar 

Paul R, Winkler F, Bayerlein I, Popp B, Hw P, Koedel U (2005) Urokinase-type plasminogen activator receptor regulates leukocyte recruitment during experimental pneumococcal meningitis. J Infect Dis 191:776–782. https://doi.org/10.1086/427829

Article  CAS  PubMed  Google Scholar 

Pfister H, Borasio G, Dirnagl U, Bauer M, Einhaupl K (1992) Cerebrovascular complications of bacterial meningitis in adults. Neurology 42:1497–1504

Article  CAS  PubMed  Google Scholar 

Robbie L, Dummer S, Booth N, Adey G, Bennett B (2000) Plasminogen activator inhibitor 2 and urokinase-type plasminogen activator in plasma and leucocytes in patients with severe sepsis. Br J Haematol 109:342–348.